Eli Lilly is selling drugs directly to patients in Australia, cutting out traditional pharmacies.
According to STAT, Eli Lilly is bypassing Australian pharmacies with a direct-to-consumer model. The report gives no further details on which drugs are involved or how the model operates.
The move marks a notable shift in how the company reaches patients in Australia, though the implications for pharmacists and patients remain unclear based on the information available.
The platform's decision highlights the vulnerability of high-profile medical crowdfunding campaigns to factual disputes.
The National Institutes of Health is launching a redesigned website that groups information into eight topic-based hubs, aiming to replace a sprawling network of more than 700 separate sites.
A new Annenberg survey finds public belief in a vaccine-autism link remains low but has slipped since 2021, while Health Secretary Kennedy's unfavorable ratings deepen amid measles outbreaks.
A county-level study links higher medical debt burdens to more late-stage cancer diagnoses, with the strongest effect seen in lung cancer.